By downregulating the EGFR signaling pathway, the cannabinoid receptor two agonist JWH-015 prevents M2 macrophage-induced epithelial-to-mesenchymal transition (EMT) in NSCLC cells (Ravi et al., 2016). Here, EGFR is linked to non-small cell lung carcinoma.